Medical Condition News

RSS

Controlled utility study results of BGM Galectin-3 test for heart failure published in cardiology journal

BG Medicine, Inc. announced today that the results of a controlled study on the utility of its galectin-3 test in heart failure were published in the Journal Clinical Research in Cardiology, a peer-reviewed, international journal that publishes original research and review articles on clinical research studies in the field of cardiology.

17 Feb 2010

Delayed introduction of complementary baby foods may influence weight: Study

Benjamin Franklin's advice that "an ounce of prevention is worth a pound of cure" can easily be applied to today's most pressing health issue: obesity. Because taking off extra weight is an almost insurmountable challenge, preventing the progression of weight gain throughout life, especially childhood, is crucial to realizing optimal long-term health.

17 Feb 2010

New fluorescent probes improve tumor detection in mice

Building on his Nobel Prize-winning work creating fluorescent proteins that light up the inner workings of cells, a team of researchers led by Howard Hughes Medical Institute investigator Roger Tsien, PhD, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego and the Moores UCSD Cancer Center has developed biological probes that can stick to and light up tumors in mice.

17 Feb 2010

Amgen and Centocor Ortho Biotech Products: FDA approves REMS for Aranesp, EPOGEN and PROCRIT ESAs

Amgen Inc. and Centocor Ortho Biotech Products, L.P., today announced that the U.S. Food and Drug Administration (FDA) has approved the Risk Evaluation and Mitigation Strategy (REMS) for erythropoiesis-stimulating agents (ESAs), which include Aranesp® (darbepoetin alfa), EPOGEN® (Epoetin alfa) and PROCRIT® (Epoetin alfa).

17 Feb 2010

Special issue reviews current state of science in fetal therapy

Repairing birth defects in the womb. Inserting a tiny laser into the mother's uterus to seal off an abnormal blood flow and save fetal twins. Advancing the science that may allow doctors to deliver cells or DNA to treat sickle cell anemia and other genetic diseases before birth.

17 Feb 2010

Quark Pharmaceuticals' QPI-1002 receives orphan drug designation from FDA

Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, announced today that the US FDA has granted orphan drug designation for QPI-1002 (also referred to as "I5NP"), a synthetic siRNA targeting p53 mRNA for the prophylaxis of delayed graft function (DGF) in kidney transplant patients.

17 Feb 2010

TopoTarget pays Celldex Therapeutics $3M sublicense income over Belinostat co-development agreement

Celldex Therapeutics, Inc. today announced that it has received a sublicense income payment of $3 million from TopoTarget A/S as a result of the recent co-development and commercialization agreement between TopoTarget and Spectrum Pharmaceuticals, Inc. for Belinostat, a novel histone deacetylase (HDAC) inhibitor for the treatment of cancer.

17 Feb 2010

American Heart Association announces strategic goal to reduce stroke and cardiovascular diseases

Racial gaps exist in women's heart-health awareness, women's knowledge of heart attack warning signs requires attention and nearly half of women report they would not call 9-1-1 if they were having heart attack symptoms, according to new research published in Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.

16 Feb 2010

Cancer Research UK, immatics Biotechnologies sign collaboration agreement to trial IMA950 vaccine for GMB

CANCER RESEARCH UK and Cancer Research Technology - the charity's development and commercialisation arm - have reached a collaboration agreement with immatics Biotechnologies to trial their new treatment vaccine, IMA950, for glioblastoma multiforme (GMB), one of the most common forms of brain cancer.

16 Feb 2010

Researchers use model organism to test new therapies for retinal degeneration

Research by Johns Hopkins sensory biologists studying fruit flies, has revealed a critical step in fly vision. Humans with problems in this same step suffer retinal dystrophies, which manifest as visual defects ranging from mild visual impairments to complete blindness.

16 Feb 2010

Eat 'heart-healthy' oats to prevent atherosclerosis

Nutritionist Mohsen Meydani, director of the Vascular Biology Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University in Boston, Mass., led the research on the oat compounds, called avenanthramides. Meydani previously has shown that phenolic antioxidants in oats obstruct the ability of blood cells to stick to artery walls.

16 Feb 2010

Positive topline data from Alkermes' phase 1 clinical study of ALKS 37 announced

Alkermes, Inc. today announced positive topline data from a phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC).

16 Feb 2010

Adding rosemary extracts in ground beef can reduce cancer-causing agents

The addition of rosemary extract to ground beef actually reduces cancer-causing agents that can form upon cooking, according to a recent study in the Journal of Food Science, published by the Institute of Food Technologists.

16 Feb 2010

Oncolytics Biotech receives U.K. MHRA approval for REOLYSIN combination Phase 3 trial

Oncolytics Biotech Inc. today announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that the Company previously reached an agreement on with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process.

16 Feb 2010

EntreMed's ENMD-2076 for AML receives FDA's orphan drug designation

EntreMed, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AML).

16 Feb 2010

MAP Pharmaceuticals initiates LEVADEX-intravenous DHE comparative trial

MAP Pharmaceuticals, Inc. today announced that the Company initiated a trial to compare the pharmacokinetics (PK), safety and metabolic profiles of LEVADEX™ orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. LEVADEX is a novel orally inhaled migraine therapy that has completed Phase 3 efficacy development for the acute treatment of migraine.

16 Feb 2010

Delcath Systems to initiate Expanded Access Program for melphalan in patients with metastatic melanoma to the liver

Delcath Systems, Inc., which is testing its proprietary treatment system for metastatic cancers to the liver, announced today that the U.S. Food and Drug Administration ("FDA") will allow the Company to initiate an Expanded Use – Intermediate Size Population protocol for the hepatic arterial infusion of melphalan with venous filtration via the Delcath PHP System™ for patients with ocular and cutaneous melanoma metastatic to the liver.

16 Feb 2010

Narcolepsy is indeed an autoimmune disorder, finds University of Lausanne study

Individuals with the sleep disorder narcolepsy suffer with excessive daytime sleepiness and attacks of muscle paralysis triggered by strong emotions (a condition known as cataplexy).

16 Feb 2010

Study explores relationship between adverse events, early antecedents and CO2 reactivity in panic disorder

A study performed by a group of Italian investigators and published in the current issue of Psychotherapy and Psychosomatics has explored the relationship between adverse events, early antecedents and carbon dioxide reactivity (CO2 reactivity) in panic disorder.

16 Feb 2010

Digestive care expert Brenda Watson's website discusses bowel movements and underlying health

Digestive Care Expert Brenda Watson’s new website takes a different look at poop with “The Poop Chronicles,” an eye-opening discussion about what our bowel movements really say about our underlying health. Combining practical information with light-hearted humor, the Poop Chronicles are chock full of digestive wisdom. For example, in the world of healthy poop, size does matter.

16 Feb 2010

Medical Condition News

Controlled utility study results of BGM Galectin-3 test for heart failure published in cardiology journal

Delayed introduction of complementary baby foods may influence weight: Study

New fluorescent probes improve tumor detection in mice

Amgen and Centocor Ortho Biotech Products: FDA approves REMS for Aranesp, EPOGEN and PROCRIT ESAs

Special issue reviews current state of science in fetal therapy

Quark Pharmaceuticals' QPI-1002 receives orphan drug designation from FDA

TopoTarget pays Celldex Therapeutics $3M sublicense income over Belinostat co-development agreement

American Heart Association announces strategic goal to reduce stroke and cardiovascular diseases

Cancer Research UK, immatics Biotechnologies sign collaboration agreement to trial IMA950 vaccine for GMB

Researchers use model organism to test new therapies for retinal degeneration

Eat 'heart-healthy' oats to prevent atherosclerosis

Positive topline data from Alkermes' phase 1 clinical study of ALKS 37 announced

Adding rosemary extracts in ground beef can reduce cancer-causing agents

Oncolytics Biotech receives U.K. MHRA approval for REOLYSIN combination Phase 3 trial

EntreMed's ENMD-2076 for AML receives FDA's orphan drug designation

MAP Pharmaceuticals initiates LEVADEX-intravenous DHE comparative trial

Delcath Systems to initiate Expanded Access Program for melphalan in patients with metastatic melanoma to the liver

Narcolepsy is indeed an autoimmune disorder, finds University of Lausanne study

Study explores relationship between adverse events, early antecedents and CO2 reactivity in panic disorder

Digestive care expert Brenda Watson's website discusses bowel movements and underlying health

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News